Literature DB >> 8201512

Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy.

R L Mones1, A R DeFelice, D Preud'Homme.   

Abstract

Ascending cholangitis after portoenterostomy for biliary atresia often leads to significant morbidity. The long-term prognosis also involves recurrent and frequently recalcitrant bouts of cholangitis. Attempts at prophylaxis with use of oral antibiotics are frequently unsuccessful. The authors describe three patients who, after successful portoenterostomies, were plagued with recurrent bouts of cholangitis, despite the use of a variety of antibiotics. The authors instituted oral neomycin as prophylaxis and nearly eliminated this serious complication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201512     DOI: 10.1016/0022-3468(94)90583-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Intravenous immunoglobulin for the treatment of intractable cholangitis after Kasai portoenterostomy in biliary atresia patients.

Authors:  Dandan Li; Pei Wang; Ying He; Chunlei Jiao; Didi Zhuansun; Nannan Wei; Jixin Yang; Jiexiong Feng
Journal:  Pediatr Surg Int       Date:  2018-02-21       Impact factor: 1.827

2.  Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.

Authors:  Vicky Lee Ng; Barbara H Haber; John C Magee; Alexander Miethke; Karen F Murray; Sonia Michail; Saul J Karpen; Nanda Kerkar; Jean P Molleston; Rene Romero; Philip Rosenthal; Kathleen B Schwarz; Benjamin L Shneider; Yumirle P Turmelle; Estella M Alonso; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.